University of Oxford
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From University of Oxford
New York biotech is partnering with researchers at Columbia, Kansas State and Southern Research to address the pandemic.
Pharma pays $100m up front and makes $20m equity investment for rights to three preclinical cancer programs. Plus more than 20 deal summaries, including COVID-19-related transactions.
The Bayh-Dole act of 1980 facilitated deal-making between private-sector firms and research institutions, largely seeding the US biotech industry. Plus, an overview of the latest tech transfer deals.
Menarini/Stemline, Supernus/US WorldMeds, BioMarin/DiNOAQOR, Adicet/ResTORbio, Vertex/Affinia, Hansoh/NiKang, plus COVID-19 deals in brief and more.
- Academic and Research Institutions
- Other Names / Subsidiaries
- Oxford University Innovation